US2019099417A1PendingUtilityA1
Abuse resistant drug formulation
Est. expirySep 15, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61K 9/1652A61K 47/44A61K 9/2018A61K 31/485A61K 9/2054A61K 9/2013A61K 9/2081A61K 9/1694A61K 9/14A61K 9/5047A61K 9/2077A61K 9/5042
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A pharmaceutical composition comprising:
a solid granulate consisting of:
an opioid or a salt thereof in an amount of about 1-80% by weight of the granulate;
a first material that is a natural or synthetic starch, a natural or synthetic cellulose, an acrylic, a vinylic, or a resin; and
a second material that is hydroxypropylmethylcellulose; and,
a coating on the granulate; wherein the first material and second material together are provided in an amount from about 0.1 to about 90 percent by weight of the formulation.
2 . The composition of claim 1 , wherein the opioid is selected from oxycodone, hydrocodone and salts thereof.
3 . The composition of claim 2 , wherein the opioid is oxycodone, or a salt thereof.
4 . The composition of claim 3 , wherein the formulation, post-administration, extends release of the oxycodone or salt thereof to a period of from at least about 6 hours to about 24 hours.
5 . The composition of claim 2 , wherein the opioid is hydrocodone, or a salt thereof.
6 . The composition of claim 2 , wherein the first material is provided in an amount from about 0.1 wt % to about 40 wt %, based on the total weight percent of the formulation.
7 . The composition of claim 2 , wherein the second material is provided in an amount from about 1 wt % to about 50 wt %, based on the total weight percent of the formulation.
8 . The composition of claim 1 , wherein the coating is selected from the group consisting of cellulose polymers, methacrylate ester copolymers, methacrylic acid copolymers, and shellac.
9 . The composition of claim 8 , wherein the coating is ethylcellulose.
10 . The composition of claim 8 , wherein the coating further comprises a fat/wax.
11 . The composition of claim 9 , wherein the fat/wax is provided in an amount between about 5 and about 40% based on the weight of the coated granulate.
12 . An extended release particle, consisting of:
an opioid or a salt thereof in an amount of about 1-80% by weight of the particle; a first material that is a natural or synthetic starch, a natural or synthetic cellulose, an acrylic, a vinylic, or a resin; and a second material that is hydroxypropylmethylcellulose; and, a coating on the particle; wherein the first material and second material together are provided in an amount from about 0.1 to about 90 percent by weight of the particle.
13 . The particle of claim 12 , wherein the opioid is selected from oxycodone, hydrocodone, and salts thereof.
14 . The particle of claim 12 , wherein the first material is provided in an amount from about 0.1 wt % to about 40 wt %, based on the total weight percent of the particle.
15 . The particle of claim 12 , wherein the second material is provided in an amount from about 1 wt % to about 50 wt %, based on the total weight of the particle.
16 . The particle of claim 13 , wherein the opioid is hydroxycodone or a salt thereof.
17 . The composition according to claim 1 , wherein the first material is at least partially soluble in an alcohol.
18 . The composition according to claim 17 , wherein the first material is at least partially soluble in ethanol.
19 . The particle according to claim 12 , wherein the first material is at least partially soluble in an alcohol.
20 . The composition according to claim 19 , wherein the first material is at least partially soluble in ethanol.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.